Jun 29, 2011:
iCo Therapeutics Announces First Quarter 2011 Financial Results

Jun 24, 2011:
iCo Therapeutics Executes Bertilimumab License with Immune Pharmaceuticals

May 31, 2011:
iCo Therapeutics CEO to Present & Participate in Panel at BioFinance 2011

May 13, 2011:
iCo Therapeutics Inc. Engages Ora for Ophthalmic Clinical & Regulatory Guidance

Apr 29, 2011:
iCo Therapeutics Announces Year-End 2010 Financial Results

Apr 14, 2011:
iCo Therapeutics Inc. Secures $10 Million Equity Line Facility

Feb 23, 2011:
iCo Therapeutics Inc. iCo-007 Program to be Presented & CEO to Sit on Panel at Retinal Physician Symposium 2011

Feb 22, 2011:
iCo Therapeutics Inc. Completes iCo-007 Phase 2 Clinical Supply Manufacturing